TRIM25 and prostate cancer: TRIM25 is overexpressed in multiple malignancies, including breast cancer [19, 21, 22], lung cancer [23, 24], liver cancer [25, 26], colorectal cancer [27], prostate cancer [28], and ovarian cancer [29].